Private equity-owned medical supply group Medline Industries jumped 41 per cent in its Wall Street debut on Wednesday after raising $6.3bn in the biggest initial public offering of 2025.
Medline’s share price closed at $41 a day after the group had priced its shares at $29 each, towards the top end of its expected range, in an upsized IPO.
Tuesday’s offering brought the deal value above the $5.4bn Medline initially anticipated and eclipsed the $5.3bn raised by Chinese battery maker Contemporary Amperex Technology Co, better known as CATL, in May.
您已閱讀18%（550字），剩余82%（2517字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。